People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Other, Other Health Care, Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Foldax, Inc. | — | Other | Series A | $38.7M | $39.4M | 2023 |
| Trireme Medical Inc | — | Other Health Care | Series A | $14.7M | $153.4M | 2010 |
| Tulavi Therapeutics, Inc. | — | Biotechnology | Series A | $14.5M | $17.9M | 2021 |
| Apama Medical, Inc. | — | Healthtech | Series A | $14.3M | $297.4M | 2016 |
Greg Casciaro at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Greg Casciaro on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| FARHAD KHOSRAVI | 2 | 14 |
| Henry Chen | 2 | 7 |
| Tara Butler | 1 | 12 |
| AMR SALAHIEH | 1 | 10 |
| Brant Heise | 1 | 10 |
| Mark Wan | 1 | 10 |
| George Wallace | 1 | 8 |
| Scott Huennekens | 1 | 7 |
| Amir Belson | 1 | 6 |
| Amar Sawhney | 1 | 6 |
| Morteza Gharib | 1 | 5 |
| James Demetriades | 1 | 4 |
| Kenneth Charhut | 1 | 4 |
| Michael Lynn | 1 | 3 |
| Rob Kuhling | 1 | 3 |
| Ken Charhut | 1 | 3 |
| Mory Gharib | 1 | 3 |
| Renee Masi | 1 | 3 |
| MOTASIM SIRHAN | 1 | 2 |
| Tara Butler, M.D. | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.